Sort
30,917 grants matching “tumor microenvironment”
Transport of Effector T cells and Nano-DC vaccine in Breast Cancer
$502,945Elizabeth Mittendorf · Methodist Hospital Research Institute · U54 · FY2016 · CA
TARGETING AML-STROMAL INTERACTIONS
$502,925John F Dipersio · Washington University · R01 · FY2012 · CA
(PQ1) Progenitor cell malfunction, mutations and changes in microenvironment: A dynamic risk spectrum for cancer evolution
$502,882Moumita Ghosh · University Of Colorado Denver · R01 · FY2021 · CA
Data Science Core
$502,676Ming Li · University Of Southern California · P30 · FY2024 · CA
Exploring the potential of TET inhibition in cancer immunotherapy
$502,630Anjana Rao · La Jolla Institute For Immunology · R01 · FY2020 · CA
Exploring the potential of TET inhibition in cancer immunotherapy
$502,630Anjana Rao · La Jolla Institute For Immunology · R01 · FY2021 · CA
CHI3L1-targeted small molecules for glioblastoma
$502,588Moustafa Gabr · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · NS
CHI3L1-targeted small molecules for glioblastoma
$502,588Moustafa Gabr · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · NS
Rewiring Cancer-Induced Abnormalities in the Vascular Barrier
$502,563Luisa Iruela-Arispe · Northwestern University At Chicago · R01 · FY2024 · CA
TOPAS - nBio, a Monte Carlo tool for radiation biology research
$502,535Jan Patrick Oscar Schuemann · Massachusetts General Hospital · R01 · FY2024 · CA
Systems analysis of mechanisms driving response to immunotherapy in clear cell cancers
$502,504Andrew J. Gentles · Stanford University · U01 · FY2023 · CA
Tumor-promoting liver injuries and mechanisms
$502,440Gen-Sheng Feng · University Of California, San Diego · R01 · FY2021 · CA
Targeting Hypoxia-Induced Cancer-Cell Adaptation by Direct Inhibition of Akt and
$502,289Maurizio Pellecchia · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2010 · CA
Modeling Response to HER2 target therapies
$502,262Joe W. Gray · University Of Calif-Lawrenc Berkeley Lab · U54 · FY2011 · CA
miR-155 targeted therapeutics for precision medicine in lung cancer
$502,255George A. Calin · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA
Project 1: Combinatorial adjuvants promote uniform and selective intratumoral CTL infiltration in colorectal cancer
$502,126Pawel Kalinski · Roswell Park Cancer Institute Corp · P01 · FY2023 · CA
miR-155 targeted therapeutics for precision medicine in lung cancer
$501,986George A. Calin · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Tumor-promoting and tumor-suppressive roles of Hepatic Stellate Cell Subpopulations in NASH-HCC
$501,946Robert F. Schwabe · Columbia University Health Sciences · R01 · FY2023 · CA
Targeting immunoproteasome-mediated antigen presentation in colorectal cancer immunotherapy
$501,827Xinna Zhang · Indiana University Indianapolis · R01 · FY2025 · CA
Targeting immunoproteasome-mediated antigen presentation in colorectal cancer immunotherapy
$501,827Xiongbin Lu · Indiana University Indianapolis · R01 · FY2022 · CA
Mechanistic maps of adaptive responses to therapeutic stress to optimize combination therapies.
$501,790Gordon B. Mills · Oregon Health & Science University · U01 · FY2024 · CA
Myofibroblasts in Gastrointestinal Cancers
$501,771Timothy Cragin Wang · Columbia University Health Sciences · U54 · FY2015 · CA
Nanoparticles-mediated combination therapy for breast cancer
$501,746Song Li · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
Investigating the roles of extracellular cGAMP and harnessing it for cancer treatment
$501,670Lingyin Li · Stanford University · R01 · FY2021 · CA
Sunitinib Modulation of Cancer Immunotherapy
$501,600James H Finke · Cleveland Clinic Lerner Com-Cwru · R01 · FY2014 · CA